Anti-PDE3B antibody [EPR28229-71] - BSA and Azide free
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal PDE3B antibody. Carrier free. Suitable for Dot, WB, IP and reacts with Recombinant fragment - Human, Human samples.
View Alternative Names
CGIPDE1, Cyclic GMP-inhibited phosphodiesterase B, CGIP1, CGI-PDE B, PDE3B
- IP
Supplier Data
Immunoprecipitation - Anti-PDE3B antibody [EPR28229-71] - BSA and Azide free (AB317027)
This data was developed using ab317026, the same antibody clone in a different buffer formulation.
PDE3B was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate with ab317026 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab317026 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : ab317026 IP in HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab317026 in HeLa whole cell lysate
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
All lanes:
Immunoprecipitation - Anti-PDE3B antibody [EPR28229-71] (<a href='/en-us/products/primary-antibodies/pde3b-antibody-epr28229-71-ab317026'>ab317026</a>) at 1/30 dilution
All lanes:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate with 5% NFDM/TBST
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 24s
- WB
Supplier Data
Western blot - Anti-PDE3B antibody [EPR28229-71] - BSA and Azide free (AB317027)
This data was developed using ab317026, the same antibody clone in a different buffer formulation.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
The identity of the lower MW band at approximately 20 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-PDE3B antibody [EPR28229-71] (<a href='/en-us/products/primary-antibodies/pde3b-antibody-epr28229-71-ab317026'>ab317026</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg with 5% NFDM/TBST
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg with 5% NFDM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 145 kDa,36 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-PDE3B antibody [EPR28229-71] - BSA and Azide free (AB317027)
This data was developed using ab317026, the same antibody clone in a different buffer formulation.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
The identity of the lower MW band at approximately 20 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-PDE3B antibody [EPR28229-71] (<a href='/en-us/products/primary-antibodies/pde3b-antibody-epr28229-71-ab317026'>ab317026</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg with 5% NFDM/TBST
Lane 2:
HeLa transfected with siRNA specifically targeting PDE3B whole cell lysate at 20 µg with 5% NFDM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 145 kDa,36 kDa
false
Exposure time: 59s
- WB
Supplier Data
Western blot - Anti-PDE3B antibody [EPR28229-71] - BSA and Azide free (AB317027)
This data was developed using ab317026, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : human skeletal muscle.
The identity of the lower MW band at approximately 20 kDa is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-PDE3B antibody [EPR28229-71] (<a href='/en-us/products/primary-antibodies/pde3b-antibody-epr28229-71-ab317026'>ab317026</a>) at 1/1000 dilution
Lane 1:
Human adipocytes tissue lysate at 20 µg
Lane 2:
Human liver tissue lysate at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 145 kDa,36 kDa
false
Exposure time: 70s
- Dot
Supplier Data
Dot Blot - Anti-PDE3B antibody [EPR28229-71] - BSA and Azide free (AB317027)
This data was developed using ab317026, the same antibody clone in a different buffer formulation.
Dot blot analysis of PDE3B using ab317026 at 1 : 1000 (0.498 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This antibody does not cross-react with human PDE3A.
All lanes:
Dot Blot - Anti-PDE3B antibody [EPR28229-71] (<a href='/en-us/products/primary-antibodies/pde3b-antibody-epr28229-71-ab317026'>ab317026</a>) at 1/1000 dilution
Lane 1:
His-tagged human PDE3B protein
Lane 2:
His-tagged human PDE3A protein
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-PDE3B antibody [EPR28229-71]
Reactivity data
Product details
ab317027 is the carrirer-free version of ab317026.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
In adipose tissue and liver PDE3B modulates lipogenesis and lipolysis which are vital processes for energy balance. This enzyme interacts with signaling pathways that involve protein kinase A (PKA) and insulin signaling. PDE3B operates as part of larger protein complexes and influences the metabolic rate by regulating the availability of the cAMP for phosphorylation reactions. The activity of PDE3B links closely to the control of energy homeostasis due to its regulatory function on lipid metabolism.
Pathways
PDE3B is integral to the insulin signaling pathway and adiponectin signaling pathway both important in glucose and lipid homeostasis. Within these pathways it functions alongside proteins like AKT and PKA where its activity modulates their signaling efficiency. By controlling the balance of cAMP PDE3B influences signaling cascades that are important for the adaptive cellular responses to hormones and nutrients.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com